Lahelma, M. et al. 2024. Prognostic factors and overall survival among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland study. Acta Oncologica. 63, 1 (Oct. 2024), 763–771. DOI:https://doi.org/10.2340/1651-226X.2024.40324.